Back

Effects of upgrade versus de-novo cardiac resynchronization therapy on clinical response and long-term survival: Results form a large multicenter study

28 August 2016 (16:30 - 16:39)
Organised by:
Congress Presentation Part of: Clinical results in CRT: patient groups, leads and optimisation Resynchronisation therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

9 More presentations in this session

Presentation thumbnail
A novel algorithm increases effective left ventricular pacing during atrial fibrillation in patients undergoing cardiac resynchronization therapy: primary results of the randomized CRTee trial
Doctor S. Mittal (Ridgewood, US)
Abstract Slides Video
Presentation thumbnail
Early AV node ablation versus pharmacological rate control in patients with CRT and AF. Results of SPARE III, a randomized multicenter study.
Doctor M. Trucco (Girona, ES)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronization therapy defibrillator at the end of battery life; is time to discuss the need to re-implant a device with defibrillator back-up in all patients?
Doctor R. Rordorf (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Device-related infective endocarditis in cardiac resynchronization therapy recipients - single center registry with over 2500 person-years follow up
Mrs E. Jedrzejczyk-Patej (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Impact of multi-point left ventricular pacing on left ventricular ejection fraction: preliminary results from an italian multicenter prospective registry (iron mpp).
Doctor L. Santini (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical results in CRT: patient groups, leads and optimisation

The Event

Event poster

ESC Congress 2016

28 August 2016 16:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources